ABCL - 1313
Prior Bendamustine Exposure Within 12 Months and Outcomes After CAR-T or Bispecific Antibody Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Real-World Analysis
Archit Srivastava
Poster Presenter: Archit Srivastava
